Pargyline-induced myopathy with histochemical characteristics of Duchenne muscular dystrophy.
D000109:Acetylcholine / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D001012:Aorta, Abdominal / Q000503:physiopathology; D001679:Biogenic Amines / Q000378:metabolism*; D004195:Disease Models, Animal; D005260:Female; D006651:Histocytochemistry; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008026:Ligation; D008856:Microscopy, Fluorescence; D009121:Muscle Denervation; D009132:Muscles / Q000187:drug effects / Q000473:pathology; D009136:Muscular Dystrophies / Q000139:chemically induced* / Q000201:enzymology / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009469:Neuromuscular Junction / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010088:Oxidoreductases / Q000378:metabolism; D010293:Pargyline; D051381:Rats; D012584:Sciatic Nerve / Q000503:physiopathology
D001679:Biogenic Amines; D010293:Pargyline; D010088:Oxidoreductases; D007770:L-Lactate Dehydrogenase; D000251:Adenosine Triphosphatases; D000109:Acetylcholine; D009638:Norepinephrine